Additional information
| Active substance | Anastrozole |
|---|---|
| Active Half-Life | 2 days |
| Classification | Non-steroidal aromatase inhibitor |
| Dosage | 0.5-1 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Blood estrogen levels |
| Also known as | AI, Anastrozole |
| Blood pressure | Little to no effect on blood pressure |
| Trade name | Arimidex |
| FORM | Oral |
| Dosage Unit | Tabs |
| ean13 | 1398603914077 |
| Reference | BLG23 |
| Tab Piece | 50 Tabs |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | Anastrozole |
| Formula | C17H19N5 |
| Substance class | Aromatase inhibitor |
| Main action | Reduces estrogen production |
| Half-life | 46.8 hours |
| Dosage (medical) | 1 mg per day |
| Dosage (sports) | 0.5 mg to 1 mg every other day |
| Effects | Decreases circulating estrogen levels, increases testosterone levels |
| Side effects | Joint pain, nausea, hot flashes, weakness |
| Use in sports | Used to counteract estrogenic side effects of anabolic steroids |
| Packing | Bottle |
Reviews
There are no reviews yet.